ECO 2026
ECO 2026 12 - 15 May 2026

Characterisation of CagriSema dose reductions in the REDEFINE 1 trial

Authors :

W. Timothy Garvey1; Jaime P. Almandoz2; Mikkel Hovden Christensen3; Cynthia Karenina Osorto Contreras3; Anthony N. Fabricatore4; Thomas Bo Jensen3; Michael G. Knight5; Kirsi H. Pietiläinen6;7; Carel W. le Roux8;
Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Download .PDF
Keywords
Obesity
Congress poster
Amylin
CagriSema
PHASE 3 (RCT)